CEO of activist hedge fund Starboard: 'We are certainly interested in the story at Bristol-Myers'
February 05, 2019 at 12:49 PM EST
Smith refused to comment on a weekend report about Starboard taking a stake in the embattled pharmaceutical giant, which last month agreed to buy troubled cancer drug company Celgene in a cash and stock deal valued at $74 billion.